Changing etiologies and outcomes of acute liver failure: Perspectives from 6 transplant centers in Argentina

Liver Transplantation

Volumn 20, Issue 4, 2014, Pages 483-489

  Mendizabal, Manuel ^a   Marciano, Sebastián ^b   Videla, María G ^c   Anders, Margarita ^d   Zerega, Alina ^e   Balderramo, Domingo C ^f   Chan, Débora ^a   Barrabino, Martín ^f   Gil, Octavio ^e   Mastai, Ricardo ^d   Yantorno, Silvina ^c   Gadano, Adrián ^b   Silva, Marcelo O ^a  

^a UNIVERSIDAD AUSTRAL   (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^d HOSPITAL ALEMÁN   (Argentina)

^e Sanatorio Allende   (Argentina)

^f HOSPITAL PRIVADO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LIVER FAILURE; ADULT; ADVERSE OUTCOME; ARGENTINA; ARTICLE; AUTOIMMUNE HEPATITIS; DEATH; FEMALE; HEPATITIS VIRUS; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; CLINICAL TRIAL; HEPATITIS B; HEPATITIS, AUTOIMMUNE; LIVER FAILURE, ACUTE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ADULT; ARGENTINA; FEMALE; HEPATITIS B; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84897108968     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23823     Document Type: Article

References (29)

1. Lee WM, Stravitz RT, Larson AM,. Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011. Hepatology 2012; 55: 965-967.
2. Bernal W, Hyyrylainen A, Gera A, Audimoolam VK, McPhail MJ, Auzinger G, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol 2013; 59: 74-80.
3. Germani G, Theocharidou E, Adam R, Karam V, Wendon J, O'Grady J, et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol 2012; 57: 288-296.
4. Lee WM,. Etiologies of acute liver failure. Semin Liver Dis 2008; 28: 142-152.
5. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podestá LG, Villamil FG,. MELD is superior to King's College and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007; 13: 822-828.
6. O'Grady JG, Schalm SW, Williams R,. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-275.
7. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al.; for International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176.
8. Bernal W, Ma Y, Smith HM, Portmann B, Wendon J, Vergani D,. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007; 47: 664-670.
9. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT,. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721.
10. O'Grady JG, Alexander GJ, Hayllar KM, Williams R,. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-445.
11. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648-651.
12. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al.; for United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
13. Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA,. Systematic review: acute liver failure-one disease, more than 40 definitions. Aliment Pharmacol Ther 2012; 35: 1245-1256.
14. Escorsell A, Mas A, de la Mata M,; for Spanish Group for the Study of Acute Liver Failure. Acute liver failure in Spain: analysis of 267 cases. Liver Transpl 2007; 13: 1389-1395.
15. Wei G, Bergquist A, Broomé U, Lindgren S, Wallerstedt S, Almer S, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007; 262: 393-401.
16. Court MH, Freytsis M, Wang X, Peter I, Guillemette C, Hazarika S, et al.; for Acute Liver Failure Study Group. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure. J Pharmacol Exp Ther 2013; 345: 297-307.
17. Czaja AJ,. Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Rev Gastroenterol Hepatol 2013; 7: 365-385.
18. Stravitz RT, Lefkowitch JH, Fontana RJ, Gershwin ME, Leung PS, Sterling RK, et al.; for Acute Liver Failure Study Group. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011; 53: 517-526.
19. Acharya SK, Panda SK, Saxena A, Gupta SD,. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol 2000; 15: 473-479.
20. Cervio G, Trentadue J, D'Agostino D, Luque C, Giorgi M, Armoni J, Debbag R,. Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program. Hepat Med 2011; 3: 99-106.
21. Vacchino MN,. Incidence of hepatitis A in Argentina after vaccination. J Viral Hepat 2008; 15 (suppl 2): 47-50.
22. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J,. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163-169.
23. Pauwels A, Mostefa-Kara N, Florent C, Lévy VG,. Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol 1993; 17: 124-127.
24. Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int 2007; 27: 329-334.
25. McPhail MJ, Wendon JA, Bernal W,. Meta-analysis of performance of Kings's College Hospital criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol 2010; 53: 492-499.
26. Peláez-Luna M, Martinez-Salgado J, Olivera-Martinez MA,. Utility of the Mayo End-Stage Liver Disease score, King's College criteria, and a new in-hospital mortality score in the prognosis of in-hospital mortality in acute liver failure. Transplant Proc 2006; 38: 927-929.
27. Schmidt LE, Larsen FS,. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 2007; 45: 789-796.
28. Bechmann LP, Jochum C, Kocabayoglu P, Sowa JP, Kassalik M, Gieseler RK, et al. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol 2010; 53: 639-647.
29. Rutherford A, King LY, Hynan LS, Vedvyas C, Lin W, Lee WM, Chung RT,; for ALF Study Group. Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology 2012; 143: 1237-1243.